Natural Beauty Bio-Technology Limited
Symbole: 0157.HK
HKSE
0.51
HKDPrix du marché aujourd'hui
-67.5714
Ratio P/E
-2.4025
Ratio PEG
1.02B
Cap MRK
- 0.00%
Rendement DIV
Natural Beauty Bio-Technology Limited (0157-HK) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 166.8 | 168.6 | 197.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 8.1 | 8 | 8.9 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 85.4 | 80.9 | 119.9 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 77.6 | 98.8 | 121 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 13.3 | 16.3 | 12.1 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 343 | 364.6 | 450 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 270.6 | 238.4 | 417.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 25.2 | 25.7 | 29.6 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 25.7 | 35.3 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 25.2 | 51.4 | 64.9 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 217.7 | 228.7 | 9.5 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 24.4 | 25.2 | 25 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 1.6 | -24.7 | -29.3 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 539.5 | 518.9 | 487.1 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 882.6 | 883.5 | 937.2 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 20.7 | 9.8 | 15.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 171.7 | 119.4 | 94.8 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 3 | 7.5 | 19.3 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 3.5 | 6 | 9.5 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 24.1 | 24.8 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 71.2 | 104.8 | 114.4 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 24.7 | 35.3 | 41.3 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 11.1 | 18 | 24.8 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 308.1 | 286.1 | 279.2 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 200.2 | 200.2 | 200.2 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 39.1 | 54.6 | 85.4 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 263.6 | 271.1 | 294.7 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 71.6 | 71.6 | 77.6 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 574.5 | 597.5 | 657.9 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 882.6 | 883.5 | 937.2 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 574.5 | 597.5 | 657.9 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 225.8 | 236.7 | 18.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 186.3 | 143.5 | 129.1 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 27.5 | -17.1 | -59.1 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -15.1 | -30.5 | 35.3 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 26.6 | 34.3 | 35 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 4.4 | -0.1 | -35.8 | |||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 1 | 19.7 | 6.7 | |||||||||||||||||||||||
cash-flows.row.inventory | 0 | 16.5 | -1 | -27 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -16.1 | -23.3 | -16.6 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 3 | 4.4 | 1 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 0.3 | 4.6 | 8.4 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -69.1 | -44.3 | -38.1 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.3 | 8.2 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -1.3 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | -9 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 9 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -69.1 | -44 | -31.2 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -54.3 | -31.2 | -27.2 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -6 | -6 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 104 | 55.3 | 47.6 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 49.6 | 18.1 | 14.3 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1.4 | -9.9 | 4.1 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -1.8 | -27.6 | 30.1 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 158.7 | 160.6 | 188.2 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 160.6 | 188.2 | 158.2 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 16.2 | 8.3 | 42.8 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -69.1 | -44.3 | -38.1 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -52.9 | -36 | 4.7 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 336 | 335.9 | 487.8 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 157.3 | 170.6 | 206 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 178.7 | 165.3 | 281.8 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 5.8 | 7 | 4.5 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 182.5 | 188.7 | 237 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 339.8 | 359.3 | 443.1 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 1.5 | 1.7 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 8.1 | 6.2 | 4.9 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -8.1 | -0.1 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 5.8 | 7 | 4.5 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -8.1 | -0.1 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 8.1 | 6.2 | 4.9 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 26.6 | 34.3 | 35 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -3.8 | -23.4 | 44.7 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -11.9 | -23.5 | 48.5 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 3.2 | 6.9 | 13.2 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | -15.1 | -30.5 | 35.3 |
Questions fréquemment posées
Quel est le total de Natural Beauty Bio-Technology Limited (0157.HK) de l'actif total?
Natural Beauty Bio-Technology Limited (0157.HK) Le total des actifs est 882583000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.532.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -0.026.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -0.045.
Quel est le revenu total de l'entreprise?
Le revenu total est -0.011.
Qu'est-ce que Natural Beauty Bio-Technology Limited (0157.HK) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -15111000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 186287000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 182497000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.